Manchester Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.36M Sell
36,254
-336
-0.9% -$38.8K 0.63% 25
2025
Q4
$3.85M Buy
36,590
+238
+0.7% +$22.3K 0.52% 30
2025
Q3
$3.05M Sell
36,352
-2,499
-6% -$206K 0.41% 40
2025
Q2
$3.08M Sell
38,851
-3,180
-8% -$253K 0.4% 43
2025
Q1
$3.77M Sell
42,031
-632
-1% -$59K 0.46% 38
2024
Q4
$4.24M Sell
42,663
-1,573
-4% -$162K 0.49% 38
2024
Q3
$5.02M Sell
44,236
-223
-0.5% -$26.5K 0.59% 31
2024
Q2
$5.5M Buy
44,459
+277
+0.6% +$35.7K 0.66% 26
2024
Q1
$5.83M Buy
44,182
+1,154
+3% +$142K 0.72% 25
2023
Q4
$4.69M Sell
43,028
-366
-0.8% -$38K 0.63% 28
2023
Q3
$4.47M Sell
43,394
-625
-1% -$67.4K 0.66% 23
2023
Q2
$5.08M Sell
44,019
-7,914
-15% -$899K 0.68% 24
2023
Q1
$5.53M Buy
51,933
+10,810
+26% +$1.17M 0.72% 23
2022
Q4
$4.56M Sell
41,123
-1,660
-4% -$170K 0.67% 23
2022
Q3
$3.68M Buy
42,783
+1,970
+5% +$176K 0.64% 27
2022
Q2
$3.72M Buy
40,813
+2,118
+5% +$188K 0.64% 25
2022
Q1
$3.17M Sell
38,695
-1,219
-3% -$96.1K 0.46% 32
2021
Q4
$3.06M Buy
39,914
+718
+2% +$57.2K 0.4% 35
2021
Q3
$2.94M Buy
39,196
+2,100
+6% +$160K 0.4% 35
2021
Q2
$2.88M Sell
37,096
-1,574
-4% -$117K 0.4% 33
2021
Q1
$2.85M Sell
38,670
-1,587
-4% -$117K 0.42% 35
2020
Q4
$3.14M Buy
40,257
+532
+1% +$40.7K 0.49% 29
2020
Q3
$3.14M Sell
39,725
-5,691
-13% -$446K 0.49% 28
2020
Q2
$3.35M Sell
45,416
-1,006
-2% -$75.7K 0.46% 29
2020
Q1
$3.41M Buy
46,422
+1,467
+3% +$115K 0.55% 25
2019
Q4
$3.9M Buy
44,955
+807
+2% +$66.3K 0.43% 34
2019
Q3
$3.55M Sell
44,148
-519
-1% -$41.6K 0.42% 30
2019
Q2
$3.57M Sell
44,667
-925
-2% -$70.8K 0.46% 29
2019
Q1
$3.62M Buy
45,592
+1,106
+2% +$82.7K 0.46% 30
2018
Q4
$2.58M Hold
44,486
0.39% 25
2018
Q3
$3.01M Hold
44,486
0.43% 23
2018
Q2
$2.58M Buy
44,486
+5,213
+13% +$294K 0.39% 25
2018
Q1
$2.04M Buy
39,273
+325
+0.8% +$17.6K 0.33% 27
2017
Q4
$2.09M Buy
38,948
+1,153
+3% +$63.9K 0.31% 31
2017
Q3
$2.31M Hold
37,795
0.36% 23
2017
Q2
$2.31M Buy
37,795
+262
+0.7% +$15.9K 0.37% 26
2017
Q1
$2.28M Hold
37,533
0.36% 24
2016
Q4
$2.11M Sell
37,533
-8,160
-18% -$478K 0.32% 28
2016
Q3
$2.72M Sell
45,693
-3,651
-7% -$214K 0.41% 26
2016
Q2
$2.71M Hold
49,344
0.39% 27
2016
Q1
$2.49M Sell
49,344
-4,099
-8% -$201K 0.35% 30
2015
Q4
$2.69M Buy
53,443
+4,164
+8% +$210K 0.38% 31
2015
Q3
$2.32M Hold
49,279
0.39% 21
2015
Q2
$2.68M Buy
49,279
+6,288
+15% +$353K 0.42% 19
2015
Q1
$2.36M Sell
42,991
-4,963
-10% -$281K 0.37% 24
2014
Q4
$2.6M Hold
47,954
0.32% 26
2014
Q3
$2.71M Hold
47,954
0.36% 22
2014
Q2
$2.65M Sell
47,954
-420
-0.9% -$22.9K 0.35% 26
2014
Q1
$2.62M Sell
48,374
-1,865
-4% -$96.6K 0.42% 22
2013
Q4
$2.4M Buy
50,239
+65
+0.1% +$2.97K 0.37% 27
2013
Q3
$2.28M Sell
50,174
-649
-1% -$29.6K 0.39% 29
2013
Q2
$2.25M Buy
+50,823
New +$2.27M 0.42% 24

Other funds holding MRK

Manchester Capital Management's MRK Position: Q1 2026 in Review

Manchester Capital Management reduced its Merck (MRK) stake by 0.92% in Q1 2026, selling an estimated $38.8K and leaving 36,254 shares worth $4.36M. The position accounts for 0.63% of the portfolio, ranked #25.

Manchester Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.83M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Manchester Capital Management held 36,254 shares of Merck worth $4.36M as of Q1 2026.
  • Manchester Capital Management sold 336 Merck shares in Q1 2026, an estimated $38.8K.
  • Merck made up 0.63% of Manchester Capital Management's portfolio in Q1 2026, its #25 holding.
  • Manchester Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Manchester Capital Management's Merck position peaked at $5.83M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.